Full-Time

Associate Scientist

Cell Line Engineering, Cell, Assay, And Vector Engineering

Confirmed live in the last 24 hours

Shape Therapeutics

Shape Therapeutics

51-200 employees

Develops programmable RNA medicines using AI

AI & Machine Learning
Data & Analytics

Compensation Overview

$82k - $110kAnnually

+ Annual Target Bonus + Equity Grant + Relocation Bonus

Senior

Seattle, WA, USA

Requirements
  • Bachelor of Science degree in Neuroscience, Cell Biology, or related discipline
  • 4+ years of experience post-degree in an academic or industry laboratory setting
  • Experience culturing and differentiating primary and iPSC cell lines
  • Skilled in mammalian cell culture, transfection, and good aseptic technique
  • Stable cell line generation via viral transduction (lentivirus/retrovirus) or non-viral methods (piggybac)
  • Cell line banking and cryopreservation
  • qPCR/ddPCR principles and analysis
  • Western blot / ELISA
  • Flow cytometry/cell sorting
  • Ability to troubleshoot and think analytically
  • Strong work ethic
  • Collaborative team player
Responsibilities
  • Follow established protocols, analyze and communicate results with supervisor
  • Contribute to experimental design
  • Assist in cell line maintenance, generation, and tissue culture
  • Use gene editing techniques (i.e. CRISPR) to generate gene knockouts/knockins and mutations of interest
  • Perform a broad range of cell/molecular biology techniques (e.g. single cell cloning, DNA isolation, RNA isolation, cDNA generation, qPCR, ddPCR, immunoblotting, immunofluorescence, imaging etc.)
  • Maintain a detailed electronic laboratory notebook

At Shape Therapeutics Inc., employees are at the forefront of pioneering programmable RNA medicines, using cutting-edge AI and RNA technologies. The company's strong focus on developing treatments for a broad spectrum of diseases, including rare genetic disorders and neurodegenerative conditions, positions it as a leader in the biotechnology field. The integration of AI with advanced RNA and gene therapy technologies not only fosters an environment of technical innovation but also enhances its competitive edge in creating impactful medical solutions.

Company Stage

Series B

Total Funding

$147.5M

Headquarters

Seattle, Washington

Founded

2018

Growth & Insights
Headcount

6 month growth

4%

1 year growth

17%

2 year growth

35%